0001388295 2024-01-01 2024-09-30 0001388295 dei:BusinessContactMember 2024-01-01 2024-09-30 0001388295 2023-12-31 0001388295 2022-12-31 0001388295 us-gaap:RelatedPartyMember 2023-12-31 0001388295 us-gaap:RelatedPartyMember 2022-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2022-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001388295 2024-09-30 0001388295 us-gaap:RelatedPartyMember 2024-09-30 0001388295 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2024-09-30 0001388295 2023-01-01 2023-12-31 0001388295 2022-01-01 2022-12-31 0001388295 2024-07-01 2024-09-30 0001388295 2023-07-01 2023-09-30 0001388295 2023-01-01 2023-09-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001388295 us-gaap:CommonStockMember 2021-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001388295 us-gaap:RetainedEarningsMember 2021-12-31 0001388295 2021-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001388295 us-gaap:CommonStockMember 2022-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001388295 us-gaap:RetainedEarningsMember 2022-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001388295 us-gaap:CommonStockMember 2023-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001388295 us-gaap:RetainedEarningsMember 2023-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001388295 us-gaap:CommonStockMember 2024-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001388295 us-gaap:RetainedEarningsMember 2024-03-31 0001388295 2024-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001388295 us-gaap:CommonStockMember 2024-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001388295 us-gaap:RetainedEarningsMember 2024-06-30 0001388295 2024-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001388295 us-gaap:CommonStockMember 2023-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001388295 us-gaap:RetainedEarningsMember 2023-03-31 0001388295 2023-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001388295 us-gaap:CommonStockMember 2023-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001388295 us-gaap:RetainedEarningsMember 2023-06-30 0001388295 2023-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001388295 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001388295 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001388295 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001388295 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001388295 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001388295 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001388295 2024-01-01 2024-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001388295 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001388295 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001388295 2024-04-01 2024-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001388295 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001388295 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001388295 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001388295 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001388295 2023-01-01 2023-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001388295 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001388295 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001388295 2023-04-01 2023-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001388295 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001388295 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001388295 us-gaap:CommonStockMember 2024-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001388295 us-gaap:RetainedEarningsMember 2024-09-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001388295 us-gaap:CommonStockMember 2023-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001388295 us-gaap:RetainedEarningsMember 2023-09-30 0001388295 2023-09-30 0001388295 us-gaap:BuildingImprovementsMember 2023-12-31 0001388295 us-gaap:BuildingImprovementsMember 2024-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2023-01-01 2023-12-31 0001388295 ONEI:SubscriptionAndLicenseMember 2022-01-01 2022-12-31 0001388295 ONEI:TrainingAndEducationMember 2023-01-01 2023-12-31 0001388295 ONEI:TrainingAndEducationMember 2022-01-01 2022-12-31 0001388295 ONEI:SubscriptionAndLicenseMember 2024-01-01 2024-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2023-01-01 2023-09-30 0001388295 ONEI:TrainingAndEducationMember 2024-01-01 2024-09-30 0001388295 ONEI:TrainingAndEducationMember 2023-01-01 2023-09-30 0001388295 ONEI:AcquisitionAgreementMember 2022-06-28 2022-06-30 0001388295 ONEI:SeriesBOneCovertiblePreferredStockMember ONEI:AcquisitionAgreementMember 2022-06-28 2022-06-30 0001388295 ONEI:AcquisitionAgreementMember 2022-06-30 0001388295 ONEI:SeriesBOneCovertiblePreferredStockMember ONEI:AcquisitionAgreementMember 2022-06-30 0001388295 ONEI:SeriesBOneCovertiblePreferredStockMember ONEI:MetalanguageCorpMember 2022-06-28 2022-06-30 0001388295 ONEI:SoftwareMember 2023-12-31 0001388295 ONEI:RowlandDayMember 2023-01-01 2023-12-31 0001388295 ONEI:RowlandDayMember 2022-01-01 2022-12-31 0001388295 ONEI:RowlandDayMember 2023-12-31 0001388295 ONEI:RowlandDayMember 2022-12-31 0001388295 us-gaap:ConvertibleDebtMember ONEI:RowlandDayMember 2023-01-01 2023-12-31 0001388295 us-gaap:ConvertibleDebtMember ONEI:RowlandDayMember 2023-12-31 0001388295 us-gaap:CommonStockMember 2023-05-02 2023-05-02 0001388295 ONEI:SaulLealMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-05-02 2023-05-02 0001388295 ONEI:RowlandDayMember 2024-01-01 2024-09-30 0001388295 ONEI:RowlandDayMember 2024-09-30 0001388295 ONEI:RowlandDayMember 2023-01-01 2023-09-30 0001388295 ONEI:SaulLealMember 2024-01-01 2024-09-30 0001388295 ONEI:SaulLealMember 2024-09-30 0001388295 us-gaap:ConvertibleDebtMember ONEI:RowlandDayMember 2024-01-01 2024-09-30 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-09-30 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-05-10 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-05-10 2024-05-10 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-06-12 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-06-12 2024-06-12 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-08-12 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-08-12 2024-08-12 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-08-27 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-08-27 2024-08-27 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-09-26 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-09-26 2024-09-26 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-09-30 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2023-05-02 2023-05-02 0001388295 ONEI:SeriesBOnePreferredStockMember 2023-05-01 0001388295 2023-05-01 2023-05-02 0001388295 ONEI:MetalanguageCorpMember 2023-05-01 2023-05-02 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-10-01 2022-10-01 0001388295 2023-05-02 0001388295 ONEI:TwoThousandTwentyTwoMember ONEI:ConsultingAgreementMember 2017-03-01 2017-03-01 0001388295 ONEI:TwoThousandTwentyTwoMember ONEI:ConsultingAgreementMember 2017-03-01 0001388295 ONEI:TwoThousandTwentyTwoMember ONEI:ConsultingAgreementMember 2021-01-01 2021-12-31 0001388295 ONEI:TwoThousandTwentyTwoMember ONEI:ConsultingAgreementMember 2022-01-01 2022-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2008-04-28 0001388295 2008-04-01 2008-04-30 0001388295 ONEI:SeriesAOnePreferredStockMember 2023-12-31 0001388295 ONEI:SeriesAOnePreferredStockMember 2022-12-31 0001388295 ONEI:SeriesBOneCovertiblePreferredStockMember 2015-10-31 0001388295 2015-10-01 2015-10-31 0001388295 2015-10-01 2015-10-30 0001388295 ONEI:SeriesBTwoCovertiblePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBTwoPreferredStockMember 2015-10-31 0001388295 us-gaap:SeriesAPreferredStockMember 2015-10-01 2015-10-31 0001388295 ONEI:SeriesBTwoPreferredStockMember 2023-12-31 0001388295 ONEI:SeriesBTwoPreferredStockMember 2022-12-31 0001388295 srt:MinimumMember 2023-12-31 0001388295 srt:MaximumMember 2023-12-31 0001388295 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001388295 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001388295 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001388295 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001388295 srt:MinimumMember us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001388295 srt:MaximumMember us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001388295 us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001388295 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001388295 us-gaap:WarrantMember 2023-12-31 0001388295 us-gaap:EmployeeStockOptionMember 2023-06-05 2023-06-05 0001388295 us-gaap:EmployeeStockOptionMember 2023-06-05 0001388295 us-gaap:EmployeeStockOptionMember 2023-08-25 2023-08-25 0001388295 us-gaap:EmployeeStockOptionMember 2023-08-25 0001388295 ONEI:AdvisoryBoardMember 2023-10-01 2023-10-01 0001388295 ONEI:AdvisoryBoardMember 2023-10-01 0001388295 ONEI:AdvisoryBoardMember 2023-10-11 2023-10-11 0001388295 ONEI:AdvisoryBoardMember 2023-10-11 0001388295 ONEI:AdvisoryBoardMember 2023-01-31 0001388295 ONEI:AdvisoryBoardMember 2023-04-30 0001388295 ONEI:AdvisoryBoardMember 2023-07-31 0001388295 ONEI:AdvisoryBoardMember 2023-10-31 0001388295 srt:DirectorMember 2023-12-16 2023-12-16 0001388295 srt:DirectorMember 2023-12-16 0001388295 srt:DirectorMember 2023-01-01 2023-12-31 0001388295 srt:MinimumMember 2023-01-01 2023-12-31 0001388295 srt:MaximumMember 2023-01-01 2023-12-31 0001388295 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2023-12-31 0001388295 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-12-31 0001388295 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001388295 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001388295 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2023-05-01 0001388295 2024-02-06 2024-02-06 0001388295 2024-02-06 0001388295 us-gaap:SeriesAPreferredStockMember 2008-04-30 0001388295 us-gaap:SeriesAPreferredStockMember 2023-05-01 0001388295 us-gaap:SeriesAPreferredStockMember 2023-05-01 2023-05-01 0001388295 ONEI:SeriesAOnePreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2015-10-01 2015-10-31 0001388295 ONEI:MetalanguageMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-05-02 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2015-10-01 2015-10-31 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2023-12-31 0001388295 us-gaap:WarrantMember 2024-09-30 0001388295 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2024-01-24 2024-01-24 0001388295 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2024-01-24 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-05 2024-08-05 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-05 0001388295 srt:DirectorMember us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-05 2024-08-05 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-19 2024-08-19 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-19 0001388295 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001388295 us-gaap:EmployeeStockOptionMember 2024-09-30 0001388295 us-gaap:WarrantMember 2021-12-31 0001388295 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001388295 us-gaap:WarrantMember 2022-12-31 0001388295 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001388295 us-gaap:EmployeeStockOptionMember 2021-12-31 0001388295 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001388295 us-gaap:EmployeeStockOptionMember 2022-12-31 0001388295 us-gaap:EmployeeStockOptionMember 2023-12-31 0001388295 us-gaap:SubsequentEventMember 2024-01-24 2024-01-24 0001388295 us-gaap:SubsequentEventMember 2024-01-24 0001388295 us-gaap:SubsequentEventMember 2024-01-01 2024-01-01 0001388295 us-gaap:SubsequentEventMember 2024-01-01 0001388295 us-gaap:SubsequentEventMember ONEI:OEMAgreementMember 2024-10-08 2024-10-08 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember us-gaap:SubsequentEventMember 2024-10-14 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember us-gaap:SubsequentEventMember 2024-10-14 2024-10-14 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:SubsequentEventMember us-gaap:EmployeeStockMember 2024-10-29 2024-10-29 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-09-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-09-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-06-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-01 2023-06-30 0001388295 2023-01-01 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-09-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-01 2023-09-30 iso4217:USD shares iso4217:USD shares pure true 0001388295 S-1/A

P5Y

P10Y

P5Y

AMENDMENT NO. 1 ONEMETA INC. NV 20-5150818 450 South 400 East Suite 200 Bountiful UT 84010 (702) 550-0122 UniSearch, Inc. 321 W. Winnie Ln. Ste. 104 Carson City NV 89703 (775) 884-2700 Non-accelerated Filer true true false

1129935

400703

6935

6820

1143690

400703

1077475

1143690

1478178

522917

377883

281012

442435

281012

442435

221990

1025919

1042308

1025919

1042308

0.70798

8619420

5673346

4016616

0.001

50000000

0.001

2068

0.001

8619420

862

0.001

500000000

32995460

24983593

32996

24984

33992707

24156001

-33908796

-27761733

117771

-3580746

1143690

1478178

70903

1295

70903

1295

757267

157650

4074187

669550

192747

49800

464930 434499

685666

6174797

1311499

-6103894

-1310204

43169

33368

-43169

-33368

-6147063

-1343572

-0.22

-0.06

-0.22

-0.06

28546287

22249977

28546287

22249977

4309710

3051189

2068

20072409

20073

22614628

-26418161

-3783458

3563753

3564

1321937

1325501

1347431

1347

212776

214123

6660 6660 1363636

965427

-1343572

5673346

4016616

2068

24983593

24984

24156001

-27761733

-3580746

5673346

4016616

2068

24983593

24984

24156001

-27761733

-3580746

6023067

6023

3101097

3107120

216000

216

144787

145003

351459 351459 6660 6660 2946074 2085762 1772800 1773 131187 132960 8619420

-6102378

8619420 862 6101516 6102378

-6147063

2068

8619420

862

32995460

32996

33992707

-33908796

117771

2068

8619420

862

32995460

32996

33992707

-33908796

117771

-6147063

-1343572

6660 6660 2218722

145003

214123

391809

97952

685666

6935

6820

614986

-54863

-279916

357555

-2377888

-722145

210000

-210000

3107120

1325501

3107120

1325501

729232

393356

400703

7347

1129935

400703

469952 113439 6102378

965427

351459

Note 1. Basis of Presentation OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Note 2. Summary of Significant Accounting Policies Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation. Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less. Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances. As of December 31, 2023 and 2022, there was no allowance for credit losses. Property and Equipment Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 84%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zW2ua6ly7gRl" title="Property, plant and equipment, useful life">3 years</td></tr> </table> <p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zWgDe4JkWxvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Intangible Assets, and Long-Lived Assets The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of a long-lived asset is measured by comparison of the carrying amount to the expected future undiscounted cash flows that the asset is expected to generate. Any impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. During the year ended December 31, 2023, the Company evaluated the software for impairment and recorded an impairment expense of $685,666. Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions. Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates. Mezzanine equity Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future. Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zAvpKNek3Bcf" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zAaAJkexRlAj" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_ztaTSCg0uPO7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Subscription and license revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">54,483</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,295</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember__srt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zEmh3HtJkBRl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zU3lpPh08foj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">70,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,295</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. As of December 31, 2023 and 2022, deferred revenue was $0. Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the years ended December 31, 2023 and 2022, reflected in the accompanying statement of operations. Recent Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. In April 2019, the FASB issued clarification to ASU 2016-13 within ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, or ASU 2016-13. The guidance is effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023, which had no material impact on the Company’s financial statements.

Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation.

Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances. As of December 31, 2023 and 2022, there was no allowance for credit losses.

Property and Equipment Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 84%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zW2ua6ly7gRl" title="Property, plant and equipment, useful life">3 years</td></tr> </table>

Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 84%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zW2ua6ly7gRl" title="Property, plant and equipment, useful life">3 years</td></tr> </table>

P3Y

<p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zWgDe4JkWxvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Intangible Assets, and Long-Lived Assets The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of a long-lived asset is measured by comparison of the carrying amount to the expected future undiscounted cash flows that the asset is expected to generate. Any impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. During the year ended December 31, 2023, the Company evaluated the software for impairment and recorded an impairment expense of $685,666.

685666

Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Mezzanine equity Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.

Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zAvpKNek3Bcf" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zAaAJkexRlAj" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_ztaTSCg0uPO7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Subscription and license revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">54,483</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,295</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember__srt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zEmh3HtJkBRl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zU3lpPh08foj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">70,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,295</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. As of December 31, 2023 and 2022, deferred revenue was $0.

The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zAvpKNek3Bcf" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zAaAJkexRlAj" style="border-bottom: Black 1pt solid; text-align: center">Year Ended December 31, 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_ztaTSCg0uPO7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Subscription and license revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">54,483</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,295</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember__srt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zEmh3HtJkBRl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zU3lpPh08foj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">70,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,295</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

54483

1295

16420

70903

1295

Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the years ended December 31, 2023 and 2022, reflected in the accompanying statement of operations.

Recent Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. In April 2019, the FASB issued clarification to ASU 2016-13 within ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, or ASU 2016-13. The guidance is effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023, which had no material impact on the Company’s financial statements.

Note 3. Going Concern These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of December 31, 2023, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however, there is no assurance of additional funding being available.

Note 4. Software On June 30, 2022, the Company entered into an acquisition agreement with Metalanguage Corp. Per the acquisition agreement, the Company acquired all the shares of Metalanguage Corp. Per the acquisition agreement, the purchase price is comprised of $210,000 cash, <span id="xdx_908_ecustom--TemporaryEquityStockIssuedDuringPeriodShareNewIssues_c20220628__20220630__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_z85YsEIBFMO5" title="Temporary equity share issued for consideration">1,363,636 shares of Series B-1 convertible preferred shares and the right to receive contingent consideration in the form of equity. The contingent consideration for the acquisition is comprised of <span id="xdx_90A_ecustom--NumberOfSharesHeldInEscrow_c20220628__20220630__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_ztHQ3pSTnvTk" title="Number of shares held in escrow">1,363,637 shares of Series B-1 convertible preferred stock, which shall be held in escrow and will be issued upon the Company achieving sales of $5 million within 12 consecutive months prior to December 31, 2027. The day one contingent liability is $<span id="xdx_903_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember_zrAWWmqsQSQ9" title="Contingent consideration, liability">0 since the probability of achieving $5 million in sales within twelve consecutive months is low but will be re-evaluated in future periods. The total purchase price for the acquisition was determined to be $1,175,427 which consisted of $210,000 cash paid and <span id="xdx_903_ecustom--TemporaryEquityStockIssuedDuringPeriodShareNewIssues_c20220628__20220630__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_zTPRa8iVM7y2" title="Preferred B-1 shares issued for acquisition of asset, shares">1,363,636 shares of Series B-1 convertible preferred stock valued at the redemption value of $<span id="xdx_90E_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_ziwJgcy5O5E5" title="Temporary equity redemption price per share">0.70798 per share with a fair value of $<span id="xdx_90F_eus-gaap--TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c20220628__20220630__us-gaap--TypeOfArrangementAxis__custom--MetalanguageCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_zQPZX6s5b1hd" title="Preferred B-1 shares issued for acquisition of asset">965,427. The Company concluded the purchase of a single set of assets qualified as an asset acquisition and all such acquisition costs have been capitalized as software on the balance sheet. The Company estimated the useful life of the software acquired and purchased to be <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zOM0aevRD94c" title="Property, plant and equipment, useful life">3 years. During the years ended December 31, 2023 and 2022, the Company recorded $391,809 and $97,952 of amortization expense related to the software, respectively. During the year ended December 31, 2023, the Company evaluated the software for impairment and recorded an impairment expense of $685,666.As of December 31, 2023 and 2022, the software balance, net of amortization was $0 and $1,077,475, respectively.

210000

1363636 The contingent consideration for the acquisition is comprised of 1,363,637 shares of Series B-1 convertible preferred stock, which shall be held in escrow and will be issued upon the Company achieving sales of $5 million within 12 consecutive months prior to December 31, 2027. The day one contingent liability is $0 since the probability of achieving $5 million in sales within twelve consecutive months is low but will be re-evaluated in future periods. 1363637

1175427

210000

1363636

0.70798

965427

P3Y

391809

97952

685666

1077475

Note 5. Related Party Transactions Expense paid on the Company’s behalf During the years ended December 31, 2023 and 2022, Mr. Day paid $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zLPjZpbnCtAg" title="Payments to related party">469,952 and $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zot75Hcjj0oc" title="Payments to related party">113,439, respectively, of expenses related to legal, accounting payroll and other expenses on the Company’s behalf and was repaid $479,425 and $103,030, respectively. As of December 31, 2023 and 2022, the balance owed to Mr. Day was $4,337 and $13,809, respectively. Founder note Rowland W. Day II, the Company’s prior CEO agreed to provide the necessary working capital for the Company’s business. At the end of each calendar quarter the convertible promissory note is adjusted based upon the funds provided. The convertible promissory note bears interest at <span id="xdx_90E_eus-gaap--RelatedPartyTransactionRate_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--ConvertibleDebtMember_zvYxleivrYtf">5% and is convertible into Series B-1 preferred stock at the rate of $<span id="xdx_90F_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--ConvertibleDebtMember_zrJR53vyr7Ej">0.10 per share. The convertible promissory note is due upon demand. During the years ended December 31, 2023 and 2022, this Company recorded imputed interest expense of $6,660. On October 1, 2023, with no consideration given, Mr. Day agreed to waive the convertible feature on the note payable, related party. As of December 31, 2023, the note payable, related party principal balance was $221,990, with accrued interest of $33,299. As of December 31, 2022, the convertible note payable, related party principal balance was $221,990, with accrued interest of $22,198. Common stock and Series B-1 stock issuances On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230502__20230502__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFNAPrCfh6N8" title="Number of shares issued">1,772,800 shares of common stock and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230502__20230502__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember_zISfORbRSyRb" title="Number of shares issued">2,946,074 shares of Series B-1 Convertible preferred stock to Saul Leal, as stock-based compensation. Refer to Note 6 for additional disclosure related to the valuation of the shares issued. Accrued salary and interest On October 1, 2023, the Company and Mr. Day entered into a settlement and general release agreement. Per the agreement, Mr. Day agreed to settle all accrued salary and interest for service provided prior to the September 1, 2022. As a result, the Company recorded the settlement of $351,459 as a contribution to capital.

469952

113439

479425 103030

4337

13809

0.10

6660

221990

33299

221990

22198

1772800

2946074

351459

Note 6. Equity The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors. On May 1, 2023, the Company amended their articles of incorporation to increase the authorized B-1 preferred shares to <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230501__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zj74UIfRIOib" title="Preferred stock, shares authorized">8,619,420 shares. Common Stock 2023 During the year ended December 31, 2023, the Company issued 6,023,067 shares of common stock for cash and collected $3,107,120. During the year ended December 31, 2023, the Company issuance of 216,000 shares of common stock to consultants for services provided that were valued at $83,434. On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for additional stock-based compensation to be paid to Mr. Leal in connection with the Company’s acquisition of Metalanguage from Mr. Leal and in consideration of Mr. Leal’s importance in continuing to lead and expand the Company’s business on a post-acquisition basis. The Addendum provided for the additional issuance of 1,772,800 shares of common stock with a fair value of $132,960 and the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20221001__20221001__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember_zK4FVQG1l4Xb" title="Shares issued">2,946,074 shares of Series B-1 Convertible preferred stock to Saul Leal, which was recorded as stock-based compensation during the period issued and expensed immediately. The shares of common stock were valued at $0.075, the closing price of the Company’s stock on May 2, 2023. 2022 On March 1, 2017, the Company entered into a consulting agreement. As consideration for its services under the Agreement, the Company agreed to pay to the consultant <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20170301__20170301__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember_z8B4eQ0RBfZj" title="Common stock issued">847,431 restricted shares of the Company’s common stock and vest over five years. The shares were valued at $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20170301__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zuFgX7nZ6PUj" title="Shares issued price per share">0.50 per share based on estimated fair value using the cash selling price at the time of issuance and will be recognized over the service period. During the year ended December 31, 2021, the Company recorded expense of $<span id="xdx_908_eus-gaap--OtherExpenses_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember_zfnqBf9AhU2" title="Other expenses">84,743 related to this agreement. During the year ended December 31, 2022, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zlHKIcNuSbqk" title="Common stock issued">847,431 shares related to this agreement and recognized $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember_zvG3jCEYcmzc" title="Issuance costs">14,124 of expense for services provided during the year ended December 31, 2022. Additionally, and unrelated to the terms of the consulting agreement, the Company issued the consultant <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zTVE9doKX9Tc" title="Bonus issued">500,000 bonus shares in 2022. The shares were valued at $<span id="xdx_909_eus-gaap--SharePrice_iI_c20170301__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoMember_zruB8EbxRSMi" title="Shares issued price per share">0.40 per share based on estimated fair value using the cash selling price at the time of issuance and vested at issuance. During the year ended December 31, 2022, the Company issued 3,563,753 shares of common for cash and collected $1,325,501. Preferred Stock Series A Convertible Preferred Stock In April 2008, our board of directors designated 5,000,000 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $0.001. Series A has liquidation and dividend preferences. Each share of Series A has voting rights equal to the amount of shares of common stock the Series A is convertible to and is convertible on a 1 to 1.25 common share basis. As of December 31, 2023 and December 31, 2022, there are <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zzPsF8TYleW2" title="Preferred stock, shares outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zB2k6GLzb8E" title="Preferred stock, shares Outstanding">2,068 shares of Series A-1 issued and outstanding. Series B-1 Convertible Preferred Stock In October 2015, our board of directors designated <span id="xdx_905_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneCovertiblePreferredStockMember_zwgWgIRsDaof" title="Convertible preferred stock, shares">3,107,438 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with the redemption value of $0.70798 per share. Series B -1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock the series of preferred shares are convertible into. Each share is convertible on a 1 to 11 common share basis. Series B-1 preferred shares also include covenants requiring 51% of the outstanding votes of the series of stock to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. Series B-1 is included in mezzanine equity on the balance sheet, because it is convertible at the redemption value into a variable number of shares. On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20221001__20221001__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember_z1zYYwu8ioeh" title="Shares issued">2,946,074 shares of Series B-1 Convertible preferred stock to Saul Leal as stock-based compensation. The shares were valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230502__20230502__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember_zMyFDyEldEF8" title="Value issued">2,085,762 and recorded as stock-based compensation during the period issued. On September 30,2023, the Company amended their Articles of Incorporation to remove the redemption right on the Series B-1, which was reclassified from mezzanine equity to permanent equity on the balance sheet. As of December 31, 2023 and 2022, there are <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zb45y7lsLHg4" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zm6NVsnhuZu4" title="Preferred stock, shares outstanding">8,619,420 and <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zoM5E1WU9cRi" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zcUUArcPVpIa" title="Preferred stock, shares outstanding">5,673,346 shares of Series B-1 issued and outstanding, respectively. Series B-2 Convertible Preferred Stock In October 2015, our board of directors designated <span id="xdx_900_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoCovertiblePreferredStockMember_z6ZPrpoPZR5i" title="Convertible preferred stock">3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $0.001. Series B -2 have <span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_do_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_zPdIJDq8cy17" title="Liquidation preference, value">no liquidation or dividend preferences. Each share of Series B-2 has voting rights equal to the amount of shares of common stock the Series A is convertible to and is convertible on a <span id="xdx_906_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20151001__20151031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zRQLCEQQ1NY2" title="Preferred stock, convertible, terms">1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of December 31, 2023 and 2022, there are <span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_z6fIgKqCSoVj" title="Preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_z6vRolxOV7wc" title="Preferred stock, shares outstanding">no shares of Series B-2 issued and outstanding. Stock Warrants During the year ended December 31, 2023, the Company issued 350,000 common stock warrants in conjunction with stock purchase agreements. The warrants have a 5-year term and an exercise price range from $1.00 - $2.00. The common stock warrants have a relative fair value of $72,785.The Company valued the warrants using the Black-Scholes model with the with the following range of key assumptions: Stock price $<span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MinimumMember_zLJlvpf5EfUj" title="Warrant measurement input">0.167 - $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MaximumMember_zZFd7vlnUOIl" title="Warrant measurement input">0.40, Exercise price $1.00 - $2.00, Term 5 years, Volatility <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zuTzzwL5iQIb" title="Warrant measurement input">169.90% – <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVQZNUq70Gv9" title="Warrant measurement input">172.74%, Discount rate <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__srt--RangeAxis__srt--MinimumMember_zFxkMDCOkfg9" title="Warrant measurement input">3.91% – <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__srt--RangeAxis__srt--MaximumMember_zagRLwTU2YR8" title="Warrant measurement input">4.27% and a Dividend yield of <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z4zQCS1sclBh" title="Warrant measurement input">0%. The following table summarizes the stock warrant activity for the years ended December 31, 2023 and 2022: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuHWg3WrP2Me" style="width: 14%; text-align: right" title="Warrants outstanding, beginning balance">78,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zV4spuDUBkZ5" style="width: 14%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGpLCMRx7jj3" style="text-align: right" title="Warrants outstanding, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zAACa28SZYll" style="text-align: right" title="Weighted average exercise price per share, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKmWksSDCxvl" style="text-align: right" title="Warrants outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVZzCNSNlTb2" style="text-align: right" title="Weighted average exercise price per share, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQzXowj6lN0l" style="text-align: right" title="Warrants outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTjAyIkR9MN2" title="Weighted average exercise price per share, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGmOQmIA1o4c" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zsUREiQZP4W9" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfp1kkIh9GZ5" style="text-align: right" title="Warrants outstanding, beginning balance">78,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_z9MsPsgeECBj" style="text-align: right" title="Weighted average exercise price per share, beginning balance">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgt9p9jge1Fl" style="text-align: right" title="Warrants outstanding, Granted">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zh5ErddEBmak" style="text-align: right" title="Weighted average exercise price per share, Granted">1.29</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwFz5qtqiU5d" style="text-align: right" title="Warrants outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRQAaFYHjMQ7" style="text-align: right" title="Weighted average exercise price per share, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCdWneapMJ2h" style="text-align: right" title="Warrants outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBi9wp8np0nf" title="Weighted average exercise price per share, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBwnSASn7Erj" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, Expired">(78,750</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxpPLJIfgIxa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, Expired">0.50</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWMpfJs5mqk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvt5Xr4LfWb8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">1.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of December 31, 2023 the outstanding and exercisable warrants have a weighted average remaining term of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zT0BqoRWZAud">4.31 with <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_do_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvABZXXzzc59">no intrinsic value, respectively. Stock Options On June 5, 2023, the Company issued <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230605__20230605__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ziurIKX7PZkd">400,000 options to an employee. The options have a <span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dxL_c20230605__20230605__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzhM4egRz1w1" title="::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20230605__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zqrIscPynMU4">0.17. The options vest at 10% over a four-year period in equal installments on each of the succeeding four anniversary dates. The remaining <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20230605__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkPyGGbEpi5b">240,000 options vest upon the Company attaining a $60,000,000 run rate by December 31, 2025. The total fair value of these option grants at issuance was $62,002. On August 25, 2023, the Company issued <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230825__20230825__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zP6vO98YlmQa" title="Share based payment award options">125,000 options to an employee. The options have a three-month term at an exercise price of $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20230825__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zV6kJljs9ZV3" title="Exercise price">0.40 and vest upon issuance. On November 24, 2023, the options expired. The total fair value of these option grants at issuance was $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c20230825__20230825__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPk93PnNWUri" title="Option grants issuance">3,850. On October 1, 2023, the Company issued <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20231001__20231001__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zGWjhy1EF213" title="Share based payment award options">45,000 options to an advisory board member. The options have a <span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dxL_c20231001__20231001__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_z1Fh4gqJpyCk" title="Stock option term exercise price::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231001__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_z3pTSjRJaJWf" title="Exercise price">0.27 and vest upon issuance. The total fair value of these option grants at issuance was $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20231001__20231001__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zf15i8lZtmO9" title="Option grants issuance">11,572. On October 11, 2023, the Company issued <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20231011__20231011__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zNuycn2ucaZ6" title="Share based payment award options">550,000 options to an advisory board member. The options have a <span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dxL_c20231011__20231011__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zLZbFjs5ibyj" title="Stock option term exercise price::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231011__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zF9VUgFPiW9l" title="Exercise price">0.57. The options vest as follows: (i) <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20230131__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zhae660pRUe6" title="Share based payment award options vest"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20230430__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zfgaNAgknHLd" title="Share based payment award options vest"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20230731__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zFpyd6piFFBd" title="Share based payment award options vest"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20231031__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zVu0PbOFV36j" title="Share based payment award options vest">25,000 options on each of January 31, April 30, July 31, and October 31 for the years 2024 and 2025; (ii) 50,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $5,000,000 by June 30, 2024; (iii) 100,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $20,000,000 by June 30, 2025; and (iv) 200,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $40,000,000 by June 30, 2026. The total fair value of these option grants at issuance was $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20231011__20231011__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zx8Zfi9Q6LLg" title="Option grants issuance">298,275. On December 16, 2023, the Company issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20231216__20231216__srt--TitleOfIndividualAxis__srt--DirectorMember_zExt23jVkC1i" title="Share based payment award options">1,000,000 options to a director. The options have a <span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dxL_c20231216__20231216__srt--TitleOfIndividualAxis__srt--DirectorMember_znZjTn7Kzynk" title="Stock option term exercise price::XDX::P5Y">ten-year term at an exercise price of $<span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231216__srt--TitleOfIndividualAxis__srt--DirectorMember_zPk6fs1cvY8c" title="Exercise price">0.57. The options vest over a four-year period in equal installments on each of the succeeding four anniversary dates. The total fair value of these option grants at issuance was $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20231216__20231216__srt--TitleOfIndividualAxis__srt--DirectorMember_zNvqvqD93L77" title="Option grants issuance">397,140. During the year ended December 31, 2023, the Company issued 1,650,000 common stock options to consultants and a director. The options have a term ranging from three to five years with exercise prices ranging from $0.40 - $0.75. Of the 1,650,000 options, 100,000 options vest upon issuance and 1,550,000 options vest 20% at issuance and 80% over a four year period in equal installments on each of the succeeding four anniversary dates. The total fair value of these option grants at issuance was $611,764. The Company valued the stock options using the Black-Scholes model with the following range of key assumptions: Stock price $0.17 - $0.57, Exercise price $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0YZc2DUd0uk">0.27 - $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zH9qvM1Szxt5">0.75, Term 0.25 - 5 years, Volatility <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7iNEZcw6dSh">76.64% – <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zULIqGMcKIi9">172.88% and Discount rate 2.01% – 4.60%. During the year ended December 31, 2023, the Company recognized $61,569 of expense related to outstanding stock options. The following table summarizes the stock option activity for the years ended December 31, 2023 and 2022: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsSANHYIKs7i" style="text-align: right" title="Options outstanding, Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy46FR1RgOyh" title="Weighted average exercise price, Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zqVCJd9tp4wj" style="text-align: right" title="Options outstanding, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3KZdYOcrPR8" style="text-align: right" title="Weighted average exercise price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zXoQYnv6WIUd" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zpaDLK6kgrW" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zEltmz18iit1" style="text-align: right" title="Options outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zG34ItPIQc7f" style="text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zqhBo8AWFnUe" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLPK6ECk9xg9" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5RrpVOSVGUe" style="text-align: right" title="Options outstanding, Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zeefPjT5hWhk" style="text-align: right" title="Weighted average exercise price, Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znztqII73nm5" style="width: 14%; text-align: right" title="Options outstanding, Granted">3,770,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zl4DI9ljgev1" style="width: 14%; text-align: right" title="Weighted average exercise price, Granted">0.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zS4OYNd22ac9" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq5h7l6lOqCi" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zxViKmoYpQO7" style="text-align: right" title="Options outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z08eUXMBqt36" style="text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIKJA4Suv1o" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">(125,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zDi7f6V35EKi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.40</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_z3vFLKQ4JL6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">3,645,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXljwTj2KHP8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8fgXPvPVeX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">465,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOMyXaF0eV3j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of December 31, 2023, the outstanding and exercisable options have a weighted average remaining term of <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z0GWBb7mKUc">4.81 with an intrinsic value of $9,500.

500000000

0.001

50000000

0.001

8619420

6023067

3107120

216000

83434

1772800

132960

2946074

0.075

847431

0.50

84743

847431

14124

500000

0.40

3563753

1325501

5000000

0.001

1 to 1.25

2068

3107438

0.70798

1 to 11

0.51

2946074

2085762

8619420

5673346

3107438

0.001

1 to 1

350000

P5Y

1.00

2.00

72785

0.167

0.40

1.00

2.00

P5Y

1.6990

1.7274

0.0391

0.0427

The following table summarizes the stock warrant activity for the years ended December 31, 2023 and 2022: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuHWg3WrP2Me" style="width: 14%; text-align: right" title="Warrants outstanding, beginning balance">78,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zV4spuDUBkZ5" style="width: 14%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGpLCMRx7jj3" style="text-align: right" title="Warrants outstanding, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zAACa28SZYll" style="text-align: right" title="Weighted average exercise price per share, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKmWksSDCxvl" style="text-align: right" title="Warrants outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVZzCNSNlTb2" style="text-align: right" title="Weighted average exercise price per share, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQzXowj6lN0l" style="text-align: right" title="Warrants outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTjAyIkR9MN2" title="Weighted average exercise price per share, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGmOQmIA1o4c" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zsUREiQZP4W9" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfp1kkIh9GZ5" style="text-align: right" title="Warrants outstanding, beginning balance">78,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_z9MsPsgeECBj" style="text-align: right" title="Weighted average exercise price per share, beginning balance">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgt9p9jge1Fl" style="text-align: right" title="Warrants outstanding, Granted">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zh5ErddEBmak" style="text-align: right" title="Weighted average exercise price per share, Granted">1.29</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwFz5qtqiU5d" style="text-align: right" title="Warrants outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRQAaFYHjMQ7" style="text-align: right" title="Weighted average exercise price per share, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCdWneapMJ2h" style="text-align: right" title="Warrants outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBi9wp8np0nf" title="Weighted average exercise price per share, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBwnSASn7Erj" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, Expired">(78,750</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxpPLJIfgIxa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, Expired">0.50</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWMpfJs5mqk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvt5Xr4LfWb8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">1.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

78750

0.50

78750

0.50

350000

1.29

78750

0.50

350000

1.29

P4Y3M21D

400000

0.17

240000

60000000

62002

125000

0.40

3850

45000

0.27

11572

550000

0.57

25000

(ii) 50,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $5,000,000 by June 30, 2024; (iii) 100,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $20,000,000 by June 30, 2025; and (iv) 200,000 options upon the Company’s revenue from the sale of the Company’s products through customer’s channels exceeding $40,000,000 by June 30, 2026.

298275

1000000

0.57

397140

1650000

0.40

0.75

1650000

100000

1550000

611764

0.17

0.57

0.27

0.75

P0Y3M

P5Y

0.7664

1.7288

0.0201 0.0460

61569

The following table summarizes the stock option activity for the years ended December 31, 2023 and 2022: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsSANHYIKs7i" style="text-align: right" title="Options outstanding, Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy46FR1RgOyh" title="Weighted average exercise price, Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zqVCJd9tp4wj" style="text-align: right" title="Options outstanding, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3KZdYOcrPR8" style="text-align: right" title="Weighted average exercise price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zXoQYnv6WIUd" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zpaDLK6kgrW" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zEltmz18iit1" style="text-align: right" title="Options outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zG34ItPIQc7f" style="text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zqhBo8AWFnUe" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLPK6ECk9xg9" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5RrpVOSVGUe" style="text-align: right" title="Options outstanding, Balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zeefPjT5hWhk" style="text-align: right" title="Weighted average exercise price, Balance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znztqII73nm5" style="width: 14%; text-align: right" title="Options outstanding, Granted">3,770,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zl4DI9ljgev1" style="width: 14%; text-align: right" title="Weighted average exercise price, Granted">0.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zS4OYNd22ac9" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq5h7l6lOqCi" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zxViKmoYpQO7" style="text-align: right" title="Options outstanding, Forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z08eUXMBqt36" style="text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIKJA4Suv1o" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">(125,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zDi7f6V35EKi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.40</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_z3vFLKQ4JL6c" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">3,645,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXljwTj2KHP8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8fgXPvPVeX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">465,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOMyXaF0eV3j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3770000

0.43

125000

0.40

3645000

0.43

465000

0.46

P4Y9M21D

9500

Note 7. Income Tax The Company is subject to United States federal income taxes at an approximate rate of 21%. The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows: Schedule of Income Tax Rate Reconciliation <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230101__20231231_z7tUHLt5OBC6" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20220101__20221231_zF8TzocgpB71" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzClz_zwwJJ7DE1JF9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Income tax benefit computed at the statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,291,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">282,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationTrueupAndNondeductibleExpenses_maITEBzClz_zcVD5PsfgBqb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">True-up and non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,952,000</td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzClz_zPoQzByrfHmk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,243,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(237,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzClz_zXg4dUHiCURl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Significant components of the Company’s deferred tax assets and liabilities after applying enacted corporate income tax rates are as follows: Schedule of Deferred Tax Assets and Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20231231_zKJNZ4MLHdB7" style="font-weight: bold; text-align: center">As of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_493_20221231_zIVJJ5HTeac7" style="font-weight: bold; text-align: center">As of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred income tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzO9v_zjsAAsgrNKE5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: justify">Net operating losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">282,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzO9v_zMsjgzR0cFji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,525,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(282,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzO9v_zaotQBRho5q7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company has an operating loss carry forward of approximately $16,789,000.

0.21

Schedule of Income Tax Rate Reconciliation <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20230101__20231231_z7tUHLt5OBC6" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20220101__20221231_zF8TzocgpB71" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzClz_zwwJJ7DE1JF9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Income tax benefit computed at the statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,291,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">282,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationTrueupAndNondeductibleExpenses_maITEBzClz_zcVD5PsfgBqb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">True-up and non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,952,000</td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzClz_zPoQzByrfHmk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,243,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(237,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzClz_zXg4dUHiCURl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1291000

282000

1952000 -45000

-3243000

-237000

Significant components of the Company’s deferred tax assets and liabilities after applying enacted corporate income tax rates are as follows: Schedule of Deferred Tax Assets and Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20231231_zKJNZ4MLHdB7" style="font-weight: bold; text-align: center">As of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_493_20221231_zIVJJ5HTeac7" style="font-weight: bold; text-align: center">As of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred income tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzO9v_zjsAAsgrNKE5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: justify">Net operating losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">282,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzO9v_zMsjgzR0cFji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,525,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(282,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzO9v_zaotQBRho5q7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3525000

282000

3525000

282000

16789000

Note 8. Subsequent Events On January 24, 2024, the Board of Directors approved the issuance of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240124__20240124__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqgXp7lwXsqc" title="Stock options, issuance">750,000 options to a director. The options have a <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240124__20240124__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8b5POtJUG2i" title="Expected term::XDX::P10Y">ten-year term at an exercise price of $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20240124__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0zXCUGOVcO8" title="Exercise price">0.51 and vest in 4 equal annual installments beginning one year from the issuance date. Subsequent to December 31, 2023, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000.

750000

0.51

87500

0.40

35000

24254

1129935

6160

6935

16192

6820

46606

1143690

46606

1143690

583152

522917

471658

281012

16000

221990

1864831

1025919

1864831

1025919

0.001

50000000

0.001

2068

0.001

8619420

862

0.001

500000000

37790943

32995460

33965

32996

34998705

33992707

-36851759

-33908796

-1818225

117771

46606

1143690

3478

9162

14354

57124

3478

9162

14354

57124

202168

203588

653732

540092

537164

515146

1672388

3455292

25336

71253

78809

161038

139600 265893 491733 387809

904268

1055880

2896662

4544231

-900790

-1046718

-2882308

-4487107

34563

10990

60655

31462

-34563

-10990

-60655

-31462

-935353

-1057708

-2942963

-4518569

-0.03

-0.09

-0.16

-0.03

-0.09

-0.16

33721004

30224461

33312494

27820812

33721004

30224461

33312494

27820812

2068

8619420

862

32995460

32996

33992707

-33908796

117771

87500

34913

35000

84663

4448 4448 1665 1665

-937097

2068

8619420

862

33082960

33083

34118396

-34845893

-693550

582000

582

465018

465600

92338

1665 1665

-1070513

2068

8619420

862

33664960

33665

34677417

-35916406

-1204460

300000

300

224700

225000

94923

1665 1665

-935353

2068

8619420

862

37790943

33965

34998705

-36851759

-1818225

5673346

4016616

2068

24983593

24984

24156001

-27761733

-3580746

437500

437

174563

175000

30000

11970

12000

1665 1665

-542413

5673346

4016616

2068

25451093

25451

24344199

-28304146

-3934494

2936667

2937

1005063

1008000

2946074 2085762 1772800 1773 131187 132960

79666

1665 1665

-2918448

8619420

6102378

2068

30160560

30161

25561780

-31222594

-5630651

8619420

6102378

2068

30160560

30161

25561780

-31222594

-5630651

437500

437

174563

175000

50000

54146

54196

-8619420 -6102378 8619420 862 6101516 6102378 1665 1665

-1057708

2068

8619420

862

30648060

30648

31893670

-32280302

-355120

2068

8619420

862

30648060

30648

31893670

-32280302

-355120

-2942963

-4518569

4995 4995 2218722

271924

145862

293857

-775

12135

9372

318210

447693

23031

-62881

-125883

16000

-2380281

-1545458

549000

725600

1358000

72000

1274600

1358000

-1105681

-187458

1129935

400703

24254

213245

257975 352952 4448 6102378

Note 1. Basis of Presentation The accompanying unaudited interim financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the financial statements and notes thereto contained in the Company’s fiscal 2023 financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the financial statements for fiscal 2023, have been omitted. OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Note 2. Summary of Significant Accounting Policies Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation. Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less. Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances. As of September 30, 2024 and December 31, 2023, there was no allowance for credit losses. Property and Equipment Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 80%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zYbEXtN11T15" title="Estimated useful lives">3 years</td></tr> </table> Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions. Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates. Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2024 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2023</td> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240930_z4KDYzrJHlva" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2024</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930_zULCAdcZwHle" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2023</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_znK8JJsyh785" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Subscription and license revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">3,387</td> <td style="width: 1%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,876</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">44,674</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zxTsUN0kAdWd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,478</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">5,775</td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,478</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,450</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z23bQwjHzstf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">3,478</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">9,162</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">57,124</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. As of September 30, 2024 and 2023, deferred revenue was $16,000 and $0, respectively. Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the nine months ended September 30, 2024 and 2023, reflected in the accompanying statement of operations. Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation.

Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances. As of September 30, 2024 and December 31, 2023, there was no allowance for credit losses.

Property and Equipment Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 80%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zYbEXtN11T15" title="Estimated useful lives">3 years</td></tr> </table>

Schedule of Property and Equipment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 80%">Category</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 18%; font-weight: bold; text-align: center">Useful Lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Building and improvements</td><td> </td> <td><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingImprovementsMember_zYbEXtN11T15" title="Estimated useful lives">3 years</td></tr> </table>

P3Y

Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2024 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2023</td> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240930_z4KDYzrJHlva" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2024</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930_zULCAdcZwHle" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2023</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_znK8JJsyh785" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Subscription and license revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">3,387</td> <td style="width: 1%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,876</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">44,674</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zxTsUN0kAdWd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,478</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">5,775</td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,478</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,450</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z23bQwjHzstf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">3,478</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">9,162</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">57,124</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. As of September 30, 2024 and 2023, deferred revenue was $16,000 and $0, respectively.

The Company disaggregates revenue between subscription and license revenue and training and education revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2024 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended September 30, 2023</td> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240930_z4KDYzrJHlva" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2024</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930_zULCAdcZwHle" style="border-bottom: Black 1pt solid; text-align: center">Nine Months Ended September 30, 2023</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionAndLicenseMember_znK8JJsyh785" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Subscription and license revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 12%">3,387</td> <td style="width: 1%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,876</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">44,674</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TrainingAndEducationMember_zxTsUN0kAdWd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Training and education</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,478</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">5,775</td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,478</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,450</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z23bQwjHzstf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">3,478</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">9,162</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">57,124</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

10876

44674

3478

12450

14354

57124

16000

Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the nine months ended September 30, 2024 and 2023, reflected in the accompanying statement of operations.

Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Note 3. Restatement of Previously Issued Unaudited Interim Financial Statements In the course of preparing its fiscal year 2024 financial statements and reviewing comments from the Securities and Exchange Commission in relation to its Annual Report on Form 10-K for the year ended December 31, 2023, the Company identified errors in the financial statements for the its unaudited financial statements for the periods ended June 30, 2024, and September 30, 2024 (the “Interim Periods” or the “Affected Periods”). The errors pertain to overstatements in general and administrative expenses and additional paid in capital amounting to $576,160 the six months ended June 30, 2023 and the nine months ended September 30, 2023 resulting from the Company using the stock price from the most recent offering rather than the market price. The Company assessed the materiality of these misstatements on prior periods’ financial statements in accordance with SEC Staff Accounting Bulletin (“SAB”) No. 99, Materiality, codified in ASC 250 (“ASC 250”), Presentation of Financial Statements, and concluded that these misstatements were not material to any prior annual or interim periods. Accordingly, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements). A reconciliation from the amounts previously reported for the Affected Periods to the restated amounts in the Restated Financial Statements is provided for the impacted financial statement line items below for the balance sheets as of June 30, 2023 and September 30, 2023. The amounts labeled “Restatement Adjustments” represent the effects of the Restatement Adjustments. The Restatement Adjustments for the periods ending June 30, 2023, September 30, 2023 can be found in the Company’s amended Form 10-Q for the nine months ending September 30, 2024, filed on December 13, 2024. Schedule of Restatement of Financial Statements <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--StatementOfFinancialPositionAbstract_zppPIOaTDtBi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheets (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0xDIf9tTD7b" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zOPXe9GyWtU2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230630_zGu2b421HO7e" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Balance Sheet (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--AdditionalPaidInCapital_iI_zmCJU6BqDgYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Additional paid in capital</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">26,137,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">25,561,780</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zkwJjjCoUAx5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated deficit</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(31,798,754</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(31,222,594</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--StatementOfFinancialPositionAbstract_zaI1zLerr5pa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheets (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFQGUHF2ehGg" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z4GekwktqoOh" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20230930_zYAwh5VL1Ex7" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="10" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Balance Sheet (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">As of September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_iI_zp6KBJXYe0Pj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">32,469,830</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">31,893,670</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zXYrAf1tneVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated deficit</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(32,856,462</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(32,280,302</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_zN78tLZ9LcB2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Operations (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zee9YHod7ZRd" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjg4ZqCDTlCc" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20230630_zoUZM1xf6Wei" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Operations (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--GeneralAndAdministrativeExpense_zsLQJtC2brq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">General and administrative</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,516,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,940,146</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingExpenses_zRA86DKiEgRc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,064,511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,488,351</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_zexKb5qRRYJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,016,549</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,440,389</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLoss_zz6RdzEip0aj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,037,021</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,460,861</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss per share - basic and diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEv7jOQD47Ek" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwvNzgt3Bhzf" title="Loss per share - diluted">(0.15</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zj2iCfhiIEH1" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zJUcx5vTZ4Sj" title="Loss per share - diluted">0.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630_zzLWkrffsI73" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630_zUiq0xeYuS66" title="Loss per share - diluted">(0.13</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--IncomeStatementAbstract_zc7F1gaAPWbj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Operations (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVLR3Q43qba4" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZKxQmAncrI1" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230101__20230930_zVqgrIc1GvS7" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Operations (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--GeneralAndAdministrativeExpense_zpnI77pMSxsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">General and administrative</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,031,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,455,292</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingExpenses_zr4LwnP0rNd5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,120,391</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,544,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_zdTEhM9dQow8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,063,267</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,487,107</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zErh2y9iWwwl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,094,729</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,518,569</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss per share - basic and diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYNZgm9RK28c" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJGU3VNqbqSd" title="Loss per share - diluted">(0.18</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zQ7EKM7bVBZ6" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zAhAUGo5Polj" title="Loss per share - diluted">0.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930_ztjAEeNAOgYl" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zNxSJ4bjwm4g" title="Loss per share - diluted">(0.16</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--StatementOfCashFlowsAbstract_ztzdwpXOdS87" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Cash Flows (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXta5A8qwN88" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zItYBSwocrFi" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230630_z8KeWeexKRJa" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Cash Flows (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_zQRy3xaXSHV7" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,037,021</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">576,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(3,460,861</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--AdditionalSharesIssuedForPriorYearSoftwareAcquisition_zwxqeYoLs7bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional shares issued for prior year software acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,794,882</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,218,722</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivities_zkolBjLvH6G" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net cash used in operating activities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(960,625</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(960,625</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--StatementOfCashFlowsAbstract_zfDQagqQPmA9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Cash Flows (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB6qmwRWejwg" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zXzRMv2BQiJc" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930_zJAhDmULY28g" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Cash Flows (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zZk3RJr8rdYh" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(5,094,729</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">576,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,518,569</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_400_ecustom--AdditionalSharesIssuedForPriorYearSoftwareAcquisition_zoFdT4RkcIJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional shares issued for prior year software acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,794,882</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,218,722</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_z392voe7BCB6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net cash used in operating activities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,545,458</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,545,458</td><td style="text-align: left">)</td></tr> </table>

-576160

Schedule of Restatement of Financial Statements <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--StatementOfFinancialPositionAbstract_zppPIOaTDtBi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheets (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0xDIf9tTD7b" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zOPXe9GyWtU2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230630_zGu2b421HO7e" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Balance Sheet (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--AdditionalPaidInCapital_iI_zmCJU6BqDgYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Additional paid in capital</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">26,137,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">25,561,780</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zkwJjjCoUAx5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated deficit</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(31,798,754</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(31,222,594</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--StatementOfFinancialPositionAbstract_zaI1zLerr5pa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheets (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFQGUHF2ehGg" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z4GekwktqoOh" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20230930_zYAwh5VL1Ex7" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="10" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Balance Sheet (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">As of September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_iI_zp6KBJXYe0Pj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">32,469,830</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">31,893,670</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zXYrAf1tneVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated deficit</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(32,856,462</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(32,280,302</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_zN78tLZ9LcB2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Operations (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zee9YHod7ZRd" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjg4ZqCDTlCc" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20230630_zoUZM1xf6Wei" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Operations (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--GeneralAndAdministrativeExpense_zsLQJtC2brq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">General and administrative</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,516,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,940,146</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingExpenses_zRA86DKiEgRc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,064,511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,488,351</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_zexKb5qRRYJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,016,549</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,440,389</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLoss_zz6RdzEip0aj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,037,021</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,460,861</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss per share - basic and diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEv7jOQD47Ek" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwvNzgt3Bhzf" title="Loss per share - diluted">(0.15</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zj2iCfhiIEH1" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zJUcx5vTZ4Sj" title="Loss per share - diluted">0.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230630_zzLWkrffsI73" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230630_zUiq0xeYuS66" title="Loss per share - diluted">(0.13</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--IncomeStatementAbstract_zc7F1gaAPWbj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Operations (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVLR3Q43qba4" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZKxQmAncrI1" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20230101__20230930_zVqgrIc1GvS7" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Operations (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--GeneralAndAdministrativeExpense_zpnI77pMSxsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">General and administrative</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,031,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(576,160</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,455,292</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingExpenses_zr4LwnP0rNd5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,120,391</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,544,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_zdTEhM9dQow8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,063,267</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,487,107</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zErh2y9iWwwl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,094,729</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">576,160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,518,569</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss per share - basic and diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYNZgm9RK28c" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zJGU3VNqbqSd" title="Loss per share - diluted">(0.18</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zQ7EKM7bVBZ6" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zAhAUGo5Polj" title="Loss per share - diluted">0.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20230930_ztjAEeNAOgYl" title="Loss per share - basic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20230930_zNxSJ4bjwm4g" title="Loss per share - diluted">(0.16</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--StatementOfCashFlowsAbstract_ztzdwpXOdS87" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Cash Flows (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXta5A8qwN88" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zItYBSwocrFi" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230630_z8KeWeexKRJa" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Cash Flows (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the six months ended June 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_zQRy3xaXSHV7" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,037,021</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">576,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(3,460,861</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--AdditionalSharesIssuedForPriorYearSoftwareAcquisition_zwxqeYoLs7bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional shares issued for prior year software acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,794,882</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,218,722</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivities_zkolBjLvH6G" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net cash used in operating activities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(960,625</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(960,625</td><td style="text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--StatementOfCashFlowsAbstract_zfDQagqQPmA9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Cash Flows (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB6qmwRWejwg" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zXzRMv2BQiJc" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930_zJAhDmULY28g" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Statement of Cash Flows (Unaudited)</td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Reported</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Adjustment</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As Restated</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zZk3RJr8rdYh" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(5,094,729</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">576,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(4,518,569</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_400_ecustom--AdditionalSharesIssuedForPriorYearSoftwareAcquisition_zoFdT4RkcIJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional shares issued for prior year software acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,794,882</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(576,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,218,722</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_z392voe7BCB6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net cash used in operating activities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,545,458</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,545,458</td><td style="text-align: left">)</td></tr> </table>

26137940

-576160

25561780

-31798754

576160

-31222594

32469830

-576160

31893670

-32856462

576160

-32280302

3516306

-576160

2940146

4064511

-576160

3488351

-4016549

576160

-3440389

-4037021

576160

-3460861

-0.15

0.02

-0.13

4031452

-576160

3455292

5120391

-576160

4544231

-5063267

576160

-4487107

-5094729

576160

-4518569

-0.18

0.02

-0.16

-4037021

576160

-3460861

2794882 -576160 2218722

-960625

-5094729

576160

-4518569

2794882 -576160 2218722

-1545458

Note 4. Going Concern These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of September 30, 2024, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however, there is no assurance of additional funding being available.

Note 5. Related Party Transactions Advances, related party During the nine months ended September 30, 2024, Mr. Day advanced the Company $<span id="xdx_901_eus-gaap--ProceedsFromRelatedPartyDebt_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zNgkISFBMrjh" title="Proceeds from advances, related party">72,000 and was repaid $<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zhFnm4sTBq0i" title="Repayment of advances, related party">72,000. The advances are unsecured, non-interest bearing and are payable on demand. As of September 30, 2024, the advances, related party balance owed to Mr. Day were $<span id="xdx_904_eus-gaap--RelatedPartyDepositLiabilities_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zq8DfdTYGXna" title="Advances related party balance owed">0. Expense paid on the Company’s behalf During the nine months ended September 30, 2024 and 2023, Mr. Day paid $249,113 and $352,952, respectively, of expenses related to legal, accounting payroll and other expenses on the Company’s behalf and was repaid $213,042 and $262,850, respectively. As of September 30, 2024 and December 31, 2023, the balance owed to Mr. Day was $40,408 and $4,337, respectively. During the nine months ended September 30, 2024, Mr. Leal paid $<span id="xdx_908_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember_z33H17T29c9c" title="Expenses paid on the company's behalf">8,862 of expenses on the Company’s behalf. As of September 30, 2024, the balance owed to Mr. Leal was $8,862. Founder note Rowland Day, the Company’s prior CEO agreed to provide the necessary working capital for the Company’s business. At the end of each calendar quarter the convertible promissory note is adjusted based upon the funds provided. The convertible promissory note bears interest at <span id="xdx_903_eus-gaap--RelatedPartyTransactionRate_pid_dp_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--ConvertibleDebtMember_zzWJNK6T3o45">5% and was originally convertible into Series B-1 preferred stock at the rate of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember_zFYN3DMyKQM8">0.10 per share. The convertible promissory note is due upon demand. On October 1, 2023, with no consideration given, Mr. Day agreed to waive the convertible feature on the note payable, related party. During the nine months ended September 30, 2024 and 2023, this Company recorded imputed interest expense of $4,995. As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $221,990, with accrued interest of $41,623 and $33,299, respectively. Senior secured notes payable On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_90F_eus-gaap--NotesPayable_iI_c20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zUY6jIkRpgPc" title="Promissory note payable">225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zy3tSLlbhg7" title="Interest rate">14% per annum. <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20240510__20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zAMS1d5qRWCi" title="Debt maturity date description">The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_902_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20240510__20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zx3AIop8aMD" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_90B_eus-gaap--SecuritiesBorrowedIncrease_c20240510__20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zEJ8CevWjPxd" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zA0FT2eXMfd3" title="Warrants">1,000,000 warrants with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zL9yWayu5qgg" title="Exercise price">0.01 per share which shall have a term of <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240510__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zHzBAVlRqhQi" title="Warrants term">5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_904_eus-gaap--NotesPayable_iI_c20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zbGW1ALxvxya" title="Promissory note payable">216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z2hRiv4wzLye" title="Interest rate">14% per annum. <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDateDescription_c20240612__20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z29Iz9kZTdl6" title="Debt default description">The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_90F_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20240612__20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zR50cUyCVjbi" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_904_eus-gaap--SecuritiesBorrowedIncrease_c20240612__20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zQdR9cj2yOAk" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zjW94wC6mqHj" title="Warrants receivable">1,000,000 warrants with an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zTGYHYEHyAu3" title="Exercise price">0.01 per share which shall have a term of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240612__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zKZVBSGEqiU8" title="Warrants term">5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zqgWVefBQuF9" title="Promissory note payable">80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zkEdlfOJ5i87" title="Interest rate">14% per annum. The note is payable on demand. If the Lender does not demand payment, <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20240812__20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zTFl0nhBCbr9" title="Debt default description">the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_907_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20240812__20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zy07x0c0kSjk" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_901_eus-gaap--SecuritiesBorrowedIncrease_c20240812__20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zeR7WWEgirg3" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z95JPC09zK94" title="Warrants receivable">1,000,000 warrants with an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zrGUWG1bQUbe" title="Exercise price">0.01 per share which shall have a term of <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zauirBA2JvT5" title="Warrants term">5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_909_eus-gaap--NotesPayable_iI_c20240827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zZJOLjyZWY6l" title="Promissory note payable">5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zzlYaxIk2y4j" title="Interest rate">14% per annum. The note is payable on demand. If the Lender does not demand payment, <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20240827__20240827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zRmnoz0LKOub" title="Debt default description">the note matures on October 31, 2024. The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_902_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20240827__20240827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zsfg7ASydc83" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_90E_eus-gaap--SecuritiesBorrowedIncrease_c20240827__20240827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zkTdhT615iSk" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zfs9sibaSxE" title="Promissory note payable">23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zobADqJ3Btf" title="Interest rate">14% per annum. The note is payable on demand. If the Lender does not demand payment, <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20240926__20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zJtGIB9bLBt9" title="Debt maturity date description">the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_902_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20240926__20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zypgiwhhsv55" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_90B_eus-gaap--SecuritiesBorrowedIncrease_c20240926__20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z9E1ujHuDRia" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zjFOMPALHnGh" title="Warrants receivable">1,000,000 warrants with an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zkd0bjtNU8M6" title="Exercise price">0.01 per share which shall have a term of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240926__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zJLYwezl1U41" title="Warrants term">5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $<span id="xdx_90A_eus-gaap--SeniorNotesCurrent_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zpdohsjoZdEh" title="Convertible notes payable">549,000 and $<span id="xdx_900_eus-gaap--SeniorNotesCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zzFN4qNPnQdc" title="Senior secured notes payable">0, with accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrent_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zpEx9rayeKP6" title="Accrued interest">37,904 and $<span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zMnFqKr6ZxLe" title="Accrued interest">0, respectively. Accrued salary and interest On October 1, 2023, the Company and Mr. Day entered into a settlement and general release agreement. Per the agreement, Mr. Day agreed to settle all accrued salary and interest for service provided prior to September 1, 2022. As a result, the Company recorded a settlement of $351,459 as a contribution to capital during the year ended December 31, 2023. During the nine months ended September 30, 2024, the Company recorded an additional $4,448 as a contribution to capital related to the settlement. Common stock and Series B-1 stock issuances On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of 1,772,800 shares of common stock and 2,946,074 shares of Series B-1 Convertible preferred stock to Saul Leal as stock-based compensation. Refer to Note 6 for additional disclosure related to the valuation of the shares issued.

72000

249113

352952

213042 262850

40408

4337

8862

0.05

0.10

4995

221990

41623

33299

225000

0.14

The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years.

10000

1000000

0.01

P5Y

216000

0.14

The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

10000

1000000

0.01

P5Y

80000

0.14

the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

10000

1000000

0.01

P5Y

5000

0.14

the note matures on October 31, 2024. The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

10000

23000

0.14

the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

10000

1000000

0.01

P5Y

549000

37904

351459 4448

1772800

2946074

Note 6. Equity The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors. On May 1, 2023, the Articles of Incorporation of the Company were amended to increase the authorized B-1 preferred shares to <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230501__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember_zuwdXdGD4QOe" title="Preferred stock, shares authorized">8,619,420 shares. Common Stock On February 6, 2024, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000. During the quarter ended June 30, 2024, the Company issued 582,000 shares of common stock at $0.80 per share and collected $465,600. During the quarter ended September 30, 2024, the Company issued 300,000 shares of common stock at $0.75 per share and collected $225,000. Preferred Stock Series A Convertible Preferred Stock In April 2008, our board of directors designated 5,000,000 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended to decrease the authorized Series A shares to 2,068 shares of Series A. Series A has liquidation and dividend preferences. Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. <span id="xdx_903_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230501__20230501__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zEgMw74zndL6" title="Preferred stock, convertible terms">Each share of Series A is convertible on a 1 to 1.25 common share basis. As of each of September 30, 2024 and December 31, 2023, there were <span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20240930__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z2MLpMiR5bh5" title="Preferred stock, shares outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z4BARK15YoCl" title="Preferred stock, shares outstanding">2,068 shares of Series A issued and outstanding. Series B-1 Convertible Preferred Stock In October 2015, our board of directors designated 3,107,438 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with the redemption value of $0.70798 per share. Series B-1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible. Each share of Series B-1 is convertible on a 1 to 11 common share basis. The Company’s Articles of Incorporation require 51% of the outstanding votes of the Series B-1 to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. Series B-1 was included in mezzanine equity on the balance sheet, because it was convertible at the redemption value into a variable number of shares. On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of <span id="xdx_900_eus-gaap--SharesIssued_iI_c20230502__us-gaap--StatementClassOfStockAxis__custom--SeriesBOneConvertiblePreferredStockMember__srt--TitleOfIndividualAxis__custom--MetalanguageMember_z87EaybqgYF2">2,946,074 shares of Series B-1 Convertible preferred stock to Saul Leal as stock-based compensation. The shares were valued at $2,085,762 and recorded as stock-based compensation during the period issued. The Board approved the compensation to reward Mr. Leal’s performance in integrating the business of Metalanguage with the Company’s business following the Acquisition. On September 30, 2023, the Articles of Incorporation of the Company were amended to remove the redemption right of the Series B-1, which was subsequently reclassified from mezzanine equity to permanent equity on the balance sheet. As of September 30, 2024 and December 31, 2023, there are 8,619,420 shares of Series B-1 issued and outstanding. Series B-2 Convertible Preferred Stock In October 2015, our board of directors designated <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_z17BoP6wIGoa" title="Preferred stock, shares authorized">3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zWOBO1mBtun7" title="Preferred stock, par value">0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended such that no Series B-2 shares are authorized. Series B-2 have <span id="xdx_902_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_do_c20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zTnWDbRQBFYi" title="Liquidation preference, value">no liquidation or dividend preferences. <span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20151001__20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zQAMjNfZPUrk" title="Preferred stock, voting rights">Each share of Series B-2 has voting rights equal to the amount of shares of common stock the <span id="xdx_90C_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20151001__20151031__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zaFzHBrDOkq6" title="Preferred stock, convertible terms">Series A is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of September 30, 2024 and December 31, 2023, there are <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_do_c20240930__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zOdhzUextZZf" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240930__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zldiWj4qdA69" title="Preferred stock, shares outstanding"><span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_zywnU9iYWcSb" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoConvertiblePreferredStockMember_z8Dmx0PuzCm4" title="Preferred stock, shares outstanding">no shares of Series B-2 issued and outstanding. Stock Warrants The following table summarizes the stock warrant activity for the nine months ended September 30, 2024: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCtNSvDo1ZM3" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zJHIPItZ9K8j" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">1.29</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRbAVDOSJtK8" style="text-align: right" title="Warrants, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zWPgvINXC3oa" style="text-align: right" title="Weighted average exercise price per share, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZK60DWNiQN3" style="text-align: right" title="Warrants, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxhvlwL5HRt3" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zadljMIDbFPd" style="text-align: right" title="Warrants, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zol3QcCI7kjh" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziQvfTfORRqh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztqYbj8zZ243" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYffXCa24GI6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5PrTW65Byvk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">1.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of September 30, 2024 the outstanding and exercisable warrants have a weighted average remaining term of <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zE1fzlMcAYt1" title="Warrants outstanding, weighted average remaining term"><span id="xdx_90B_ecustom--WarrantsAndRightsExercisableTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHzKhq4AdmWe" title="Warrants exercisable, weighted average remaining term">3.56 with no intrinsic value, respectively. Stock Options On January 24, 2024, the board of directors approved the issuance of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zOBA05jMYie9" title="Stock options, issuance">750,000 options to a director. The options have a <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zZHvXYx4egsf" title="Options term::XDX::P10Y">ten-year term at an exercise price of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zUmTZpIt15Ra" title="Options exercise price">0.51 and vest in 4 equal annual installments beginning one year from the issuance date. The total fair value of these option grants at issuance was $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z8RqmMzbLppa" title="Option grants issuance">368,386.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zc5CvvWo72ib" title="Exercise price">0.51, Term <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_znpUew90euo" title="Term">6.25 years, Volatility <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zaRvqSI1mTq2" title="Volatility">162.68% and Discount rate <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240124__20240124__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zvErc04ucdpk" title="Discount rate">4.14%. On August 5, 2024, the board of directors approved the issuance of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_z5IFKuc2iKz" title="Stock options, issuance">100,000 options to an employee. The options have a <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zKzJ44pQGsZ2" title="Options term::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zP1qAPdnbhAi" title="Options exercise price">0.51. The options vest as follows: <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zlGlwazTZ8Ml" title="Stock options vested description">(i) 50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zcxchYoPJRS2" title="Option grants issuance">39,546.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $<span id="xdx_903_eus-gaap--SharePrice_iI_c20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zJjbHGLB19c1" title="Stock price">0.51, Exercise price $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zaNRbWvAvl38" title="Exercise price">0.51, Term <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zKcvcO1kwigl" title="Term">3.75 years, Volatility <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zbJaURrg52p" title="Volatility">120.76% and Discount rate <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zhsxELbH6qu2" title="Discount rate">3.62%. On August 19, 2024, the board of directors approved the issuance of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zih9mZR6Hvg6" title="Stock options, issuance">100,000 options to an employee. The options have a <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20240805__20240805__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zyZqGA4RdwSf" title="Options term::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_z0KI2BmSljOc" title="Options exercise price">0.51. <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zliFMgwOdxk6" title="Stock options vested description">The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested. The total fair value of these option grants at issuance was $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_pid_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zjr4aHyTN0D1" title="Option grants issuance">52,021.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $<span id="xdx_905_eus-gaap--SharePrice_iI_c20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zf33h63zzeaf" title="Stock price">0.57, Exercise price $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_z3jVYEUeCA8j" title="Exercise price">0.57, Term <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zWBuJIR6eMJ1" title="Term">3.75 years, Volatility <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zkp63XeX4i75" title="Volatility">117.27% and Discount rate <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240819__20240819__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember_zseWKhS2uqTf" title="Discount rate">3.75%. During the nine months ended September 30, 2024, the Company recognized $271,924 of expense related to outstanding stock options. The following table summarizes the stock option activity for the nine months ended September 30, 2024: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zT0GjyAwnBQj" style="width: 16%; text-align: right" title="Options outstanding, beginning balance">3,645,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z8rWfuQDjmzj" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance">0.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzWLQxKghew8" style="text-align: right" title="Options, granted">970,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2b8TCSN5gXj" style="text-align: right" title="Weighted average exercise price, granted">0.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zYH3lCdjybnd" style="text-align: right" title="Options, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zFUQX53HTG0l" style="text-align: right" title="Weighted average exercise price, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWqirKeN8Czl" style="text-align: right" title="Options, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsNY6CYUT2a1" style="text-align: right" title="Weighted average exercise price, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zTbFmzhOkptf" style="border-bottom: Black 1pt solid; text-align: right" title="Options, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ziTqoHqZhwrc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zrUvqhosIOu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">4,615,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zuAHS46SAZn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYEyYdsIW0u2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options, exercisable">580,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkfxSqr5KW0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of September 30, 2024, the outstanding and exercisable options have a weighted average remaining term of <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zgDpLj2BHiYd" title="Options outstanding, weighted average remaining term"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zcGmfTj40Vdf" title="Options exercisable, weighted average remaining term">4.96 with an intrinsic value of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfEBN1IgLvIb" title="Options outstanding, intrinsic valu"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOnMWXNOo3e1" title="Options exercisable, intrinsic value">47,450.

500000000

0.001

50000000

0.001

8619420

87500

0.40

35000

582000

0.80

465600

300000

0.75

225000

5000000

0.001

2068

Each share of Series A has voting rights equal to the amount of shares of common stock

Each share of Series A is convertible on a 1 to 1.25 common share basis.

2068

3107438

0.70798

Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock

Each share of Series B-1 is convertible on a 1 to 11 common share basis.

0.51

2946074

2085762

8619420

3107438

0.001

Each share of Series B-2 has voting rights equal to the amount of shares of common stock

Series A is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing.

The following table summarizes the stock warrant activity for the nine months ended September 30, 2024: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCtNSvDo1ZM3" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zJHIPItZ9K8j" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">1.29</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRbAVDOSJtK8" style="text-align: right" title="Warrants, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zWPgvINXC3oa" style="text-align: right" title="Weighted average exercise price per share, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZK60DWNiQN3" style="text-align: right" title="Warrants, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxhvlwL5HRt3" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zadljMIDbFPd" style="text-align: right" title="Warrants, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zol3QcCI7kjh" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziQvfTfORRqh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztqYbj8zZ243" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYffXCa24GI6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5PrTW65Byvk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">1.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

350000

1.29

350000

1.29

P3Y6M21D

750000

0.51

368386

0.51

P6Y3M

1.6268

0.0414

100000

0.51

(i) 50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options.

39546

0.51

P3Y9M

1.2076

0.0362

100000

0.51

The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested.

52021

0.57

P3Y9M

1.1727

0.0375

271924

The following table summarizes the stock option activity for the nine months ended September 30, 2024: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zT0GjyAwnBQj" style="width: 16%; text-align: right" title="Options outstanding, beginning balance">3,645,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z8rWfuQDjmzj" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance">0.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzWLQxKghew8" style="text-align: right" title="Options, granted">970,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2b8TCSN5gXj" style="text-align: right" title="Weighted average exercise price, granted">0.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zYH3lCdjybnd" style="text-align: right" title="Options, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zFUQX53HTG0l" style="text-align: right" title="Weighted average exercise price, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWqirKeN8Czl" style="text-align: right" title="Options, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsNY6CYUT2a1" style="text-align: right" title="Weighted average exercise price, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zTbFmzhOkptf" style="border-bottom: Black 1pt solid; text-align: right" title="Options, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ziTqoHqZhwrc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zrUvqhosIOu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">4,615,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zuAHS46SAZn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">0.43</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYEyYdsIW0u2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options, exercisable">580,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkfxSqr5KW0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3645000

0.43

970000

0.52

4615000

0.43

580000

0.46

P4Y11M15D

47450

Note 7: Commitments On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers. One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

Note 8: Subsequent Events On October 8, 2024, the Company entered into an OEM Agreement (the “Agreement”) with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel, whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. NICE is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language translation solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. <span id="xdx_90F_eus-gaap--InvestmentCompanyFeeWaiverTerms_c20241008__20241008__us-gaap--TypeOfArrangementAxis__custom--OEMAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAs9slW8Up2k" title="Term agreement description">The Agreement has an exclusivity period of eighteen months and an initial term of three years. Subsequent to September 30, 2024, the Company received $<span id="xdx_902_eus-gaap--ProceedsFromFeesReceived_c20241008__20241008__us-gaap--TypeOfArrangementAxis__custom--OEMAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE9MXmsq4tgk" title="Fees received">700,000 related to this agreement. On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $<span id="xdx_900_eus-gaap--NotesPayable_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyj52nIwIfA1" title="Promissory note payable">80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2ZrA4GDEUO5" title="Interest rate">14% per annum. The note is payable on demand. If the Lender does not demand payment, <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDateDescription_c20241014__20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdGR9CNpGNEe" title="Debt maturity date description">the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. <span id="xdx_905_eus-gaap--DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_c20241014__20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8cygZl4qqUl" title="Debt default description">The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $<span id="xdx_909_eus-gaap--SecuritiesBorrowedIncrease_c20241014__20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zY5brV6O0Mb1" title="Excess amount">10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrWB3NZ07Kjl" title="Warrants receivable">1,000,000 warrants with an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQIVTPOF7iPg" title="Exercise price">0.01 per share which shall have a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20241014__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpd9KC9mRcj3" title="Warrants term">5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender. On October 1, 2024, the Company agreed to issue <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxRzZuNelBC">1,200,000 options to an employee. The options have a <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3mKilueXBPh" title="::XDX::P5Y">five-year term at an exercise price of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z987N9WEhVDj">0.41. The options vest as follows: <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zC0OqYUqgmzl">(i) 75,000 Options are fully vested and exercisable; (ii) 525,000 Options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning December 31, 2024, and ending on September 30, 2028, until the 525,000 Options are 100% vested. In full satisfaction of the relevant obligation of the Company under the Participant’s employment agreement with the Company, the remaining 600,000 Option Shares will become vested and exercisable as follows until the Option Shares are 100% vested: (i) For a period of four years beginning October 1, 2024, ending September 30, 2025; October 1, 2025, ending September 30, 2026; October 1, 2026 ending September 30, 2027; and October 1, 2027 ending September 30, 2028, 150,000 Option Shares will vest (subject to meeting certain total new bookings) on September 30 of each year, beginning September 30, 2025. Vesting for each 12-month term is contingent upon Participant exceeding a minimum amount of total new bookings as determined by the Company’s board of directors or their designee. For the first term ending on September 30, 2025, Participant must exceed $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zo9w8DuOPEl3">5 million of total new bookings for the first vesting of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20241029__20241029__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--EmployeeStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgM2oDdIw3Ni">150,000 Option Shares.

The Agreement has an exclusivity period of eighteen months and an initial term of three years.

700000

80000

0.14

the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder.

10000

1000000

0.01

P5Y

1200000

0.41

(i) 75,000 Options are fully vested and exercisable; (ii) 525,000 Options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning December 31, 2024, and ending on September 30, 2028, until the 525,000 Options are 100% vested. In full satisfaction of the relevant obligation of the Company under the Participant’s employment agreement with the Company, the remaining 600,000 Option Shares will become vested and exercisable as follows until the Option Shares are 100% vested: (i) For a period of four years beginning October 1, 2024, ending September 30, 2025; October 1, 2025, ending September 30, 2026; October 1, 2026 ending September 30, 2027; and October 1, 2027 ending September 30, 2028, 150,000 Option Shares will vest (subject to meeting certain total new bookings) on September 30 of each year, beginning September 30, 2025.

150000